Core Viewpoint - Guangkang Biochemical (300804) announced an unusual trading notice, indicating that its chlorantraniliprole product has an environmental assessment design capacity of 10 tons per year, and the product has not yet been put into production. The expected contribution of this product to the company's overall performance is relatively small [1] Group 1 - The chlorantraniliprole product is currently not in production, and the company is in the process of completing the necessary production procedures [1] - The company's stock has experienced significant abnormal fluctuations, suggesting an overheated market sentiment and potential irrational trading behavior [1] - The company has issued a warning to investors about the risks associated with secondary market trading, urging rational decision-making and cautious investment [1]
广康生化：氯虫苯甲酰胺产品尚未投产